- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
OPPI appoints Bhushan Akshikar as President
Mumbai: The Organisation of Pharmaceutical Producers of India (OPPI), which represents the global research-based pharmaceutical companies in India, has appointed Bhushan Akshikar as its President for a term of two years effective 26th September 2024.
Bhushan is a seasoned business leader and has an experience of over 13 years in key leadership roles in GSK across India, Middle East, Russia CIS & Africa region. Before joining GSK, Bhushan spent 15 years with Janssen, Johnson & Johnson, in local and regional positions in India, South Korea and Belgium.
Speaking on his appointment, Bhushan Akshikar said, “I am excited and humbled to lead OPPI’s vision to collaborate with the Government of India to enhance access with innovation for patients, at such a crucial time for healthcare in our country. Over the years, OPPI’s focus has been on collective action to forge a path towards a more inclusive, innovative, and sustainable healthcare future for our country. I also extend my gratitude to the members of OPPI’s Executive Committee and I look forward to their continued support.”
Welcoming Bhushan as the President, Suresh Pattathil said “It has been my honour to serve as President of OPPI for the past two years, driving forth its vision of ‘Bharat Ke Liye’. As I transition from this role, I am pleased to handover the leadership to my esteemed colleague, Bhushan Akshikar. I am confident that Bhushan will expertly guide OPPI towards new achievements by leveraging his valuable insights, experience, steering the organization in the right direction to enable innovation, research, access and collaborations. I extend my best wishes to him and sincerely hope to witness OPPI reach new heights of success under his leadership.”
Anil Matai, Director General OPPI said, “I would like to extend my heartfelt gratitude to Suresh for his steadfast dedication to advancing OPPI’s vision of enabling a healthier India through innovative solutions. We look forward to his continued guidance. I am thrilled to welcome Bhushan to his new role. His extensive experience and thought leadership in the pharmaceutical industry will be invaluable as OPPI continues to support the nation’s healthcare objectives with a patient-centric approach. Bhushan has consistently been a strong advocate for healthcare transformation in our country. Under his leadership, we are confident to enhance our efforts to optimize patient outcomes by fostering an environment that encourages innovation and growth”.
Read also: OPPI names Anil Matai as Director General
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751